Adjuvant therapy in resected non-small cell lung cancer: current status and perspectives

20252 citationsJournal Articlediamond Open Access

Authors

Robert Pirker · Central European Cooperative Oncology Group

Abstract

Abstract Adjuvant chemotherapy increases overall survival of patients with completely resected non-small cell lung cancer. Adjuvant therapy with immune checkpoint inhibitors and tyrosine kinase inhibitors have further improved outcome in selected patients. These therapeutic achievements are discussed in the present commentary.

Topics & Keywords

Lung Cancer Diagnosis and Treatment Lung Cancer Treatments and Mutations Lung Cancer Research Studies

Publication Details

Published in: Holistic Integrative Oncology

Volume 4, Issue 1

DOI: 10.1007/s44178-024-00136-2

Field-Weighted Citation Impact: 3.27

Command Palette

Adjuvant therapy in resected non-small cell lung cancer: current status and perspectives

Authors

Abstract

Topics & Keywords

Publication Details